- BIIB +0.05%
Biogen's Higher Dose Spinraza Shows To Slow Neurodegeneration Faster In Infants With Rare Neuromuscular Disorder
Yahoo Finance · 22 hours ago
Open | 205.72 |
High | 206.50 |
Low | 203.53 |
Mkt Cap | 29.85B |
P/E (TTM) | 25.84 |
Div & Yield | N/A & N/A |
Prev. Close | 204.84 |
52 Wk. Low | 189.44 |
52 Wk. High | 269.43 |
Related stocks
American multinational biotechnology company
Biogen Inc. is an American multinational biotechnology company based in Cambridge, Massachusetts, United States specializing in the discovery, development, and delivery of therapies for the treatment of neurological diseases to patients worldwide. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 2.46B | 0.40% ▲ |
Net Income | 583.6M | 1.40% ▼ |
Diluted EPS | 5.28 | 1.70% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | $3.79 | - |
Q2 2024 | $4.02 | $5.28 |
Q1 2024 | $3.45 | $3.67 |
S&P FuturesES=F | 5,521.25-8.75 (-0.16%) |
Dow FuturesYM=F | 41,041.00-10.00 (-0.02%) |
Nasdaq FuturesNQ=F | 18,885.25-77.25 (-0.41%) |
Tesla, Inc.TSLA | 219.41+4.18% |
23.01-1.88% | |
NIO Inc.NIO | 4.2400+2.17% |